prednisolone has been researched along with Duncan Disease in 45 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both oral and intravenous acyclovir administration for seven days in the early stages of infectious mononucleosis caused an inhibition of oropharyngeal Epstein-Barr virus (EBV) replication." | 6.16 | Management of Epstein-Barr virus infections. ( Andersson, J; Ernberg, I, 1988) |
| "Prednisolone was subsequently administered instead of chemotherapy; however, multiple masses, including in the spine (case 1), and severe icterus with liver dysfunction (case 2) were exacerbated within a few months." | 5.46 | The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis. ( Amano, K; Anan-Nemoto, T; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Okuyama, A; Tabayashi, T; Takahashi, Y; Tamaru, JI; Tanaka, Y; Tokuhira, M; Tomikawa, T; Watanabe, R, 2017) |
| "A 58-year-old man with anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5-DM) developed Epstein-Barr virus (EBV)-associated malignant lymphoma as other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD) during the combined immunosuppressive therapy of high-dose prednisolone, tacrolimus, and intravenous cyclophosphamide for MDA5-DM." | 5.41 | Other iatrogenic immunodeficiency-associated lymphoproliferative disorders in a patient with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: A case report and systematic literature review. ( Arai, Y; Handa, T; Hirai, T; Morinobu, A; Nakashima, R; Nishimura, N; Niwamoto, T; Sakamoto, R; Tanizawa, K; Terada, K; Yoshizawa, A, 2023) |
| "A 63-year-old woman with active rheumatoid arthritis (RA) had been treated with methotrexate and prednisolone." | 3.74 | Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis. ( Komatsuda, A; Nimura, T; Sawada, K; Wakui, H, 2008) |
| " Four case reports are presented; 3 lymphomas and 1 multiple myeloma that developed, in heart transplant recipients receiving triple-drug immunosuppression: azathioprine, cyclosporine and prednisolone." | 3.68 | [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. ( Burtin, P; Guerci, AP; Lederlin, P; Mattei, S, 1992) |
| " She went into hematological remission 6 weeks following 40 mg/day treatment with prednisolone, but the anemia relapsed frequently when the dosage was lessened." | 2.38 | [Chronic T-cell lymphoproliferative disorder associated with pure red cell aplasia]. ( Akihama, T; Chubachi, A; Endo, Y; Kuwayama, A; Miura, A; Yoshida, K, 1989) |
| "Acquired hemophilia A (AHA) is a rare bleeding disorder caused by autoantibodies against factor VIII (FVIII)." | 1.62 | Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report. ( Hatayama, M; Igarashi, S; Inamura, J; Mizukami, Y; Okumura, T; Saito, T; Sato, K; Shindo, M; Sumi, C; Toki, Y; Torimoto, Y; Tsukada, N; Yamamoto, M, 2021) |
| "Prednisolone was subsequently administered instead of chemotherapy; however, multiple masses, including in the spine (case 1), and severe icterus with liver dysfunction (case 2) were exacerbated within a few months." | 1.46 | The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis. ( Amano, K; Anan-Nemoto, T; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Okuyama, A; Tabayashi, T; Takahashi, Y; Tamaru, JI; Tanaka, Y; Tokuhira, M; Tomikawa, T; Watanabe, R, 2017) |
| "The pathogenesis of allergic bronchopulmonary aspergillosis (ABPA) appears to be closely associated with the Th2 response." | 1.35 | Allergic bronchopulmonary aspergillosis in a 2-year-old asthmatic boy with immune dysregulation, polyendocrinopathy, enteropathy, X-linked. ( Futamura, M; Ito, K; Kamachi, Y; Ohshima, M; Sakamoto, T, 2009) |
| " A moderate to high dosage of corticosteroids suppressed the development of new skin lesions, but relapses occurred when these systemic corticosteroids were tapered." | 1.30 | Epstein-Barr virus-associated lymphoproliferative skin lesion with recurrent necrotic papulovesicles of the face. ( Jung, DY; Kim, JW; Lee, SK; Lee, WW, 1999) |
| "We report a case of mixed connective tissue disease (MCTD), in which biopsy of enlarged lymph nodes occurring as a presenting feature showed the characteristic features of Kikuchi's disease." | 1.29 | Kikuchi's disease as a presenting feature of mixed connective tissue disease. ( Bell, AL; Biggart, D; Gourley, I, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.67) | 18.7374 |
| 1990's | 10 (22.22) | 18.2507 |
| 2000's | 14 (31.11) | 29.6817 |
| 2010's | 14 (31.11) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Thieme, CJ | 1 |
| Schulz, M | 1 |
| Wehler, P | 1 |
| Anft, M | 1 |
| Amini, L | 1 |
| Blàzquez-Navarro, A | 1 |
| Stervbo, U | 1 |
| Hecht, J | 1 |
| Nienen, M | 1 |
| Stittrich, AB | 1 |
| Choi, M | 1 |
| Zgoura, P | 1 |
| Viebahn, R | 1 |
| Schmueck-Henneresse, M | 1 |
| Reinke, P | 2 |
| Westhoff, TH | 1 |
| Roch, T | 1 |
| Babel, N | 1 |
| Nishimura, N | 1 |
| Niwamoto, T | 1 |
| Arai, Y | 1 |
| Nakashima, R | 1 |
| Terada, K | 1 |
| Yoshizawa, A | 1 |
| Sakamoto, R | 1 |
| Tanizawa, K | 1 |
| Handa, T | 1 |
| Morinobu, A | 1 |
| Hirai, T | 1 |
| Ciullini Mannurita, S | 1 |
| Goda, R | 1 |
| Schiavo, E | 1 |
| Coniglio, ML | 1 |
| Azzali, A | 1 |
| Fotzi, I | 1 |
| Tondo, A | 1 |
| Tintori, V | 1 |
| Frenos, S | 1 |
| Sanvito, MC | 1 |
| Vignoli, M | 1 |
| Luceri, C | 1 |
| Bigagli, E | 1 |
| Grassi, A | 1 |
| D'Elios, MM | 1 |
| Favre, C | 1 |
| Gambineri, E | 1 |
| Yamamoto, M | 2 |
| Shindo, M | 1 |
| Sumi, C | 1 |
| Igarashi, S | 1 |
| Saito, T | 1 |
| Tsukada, N | 1 |
| Toki, Y | 1 |
| Hatayama, M | 1 |
| Inamura, J | 1 |
| Sato, K | 2 |
| Mizukami, Y | 1 |
| Torimoto, Y | 1 |
| Okumura, T | 1 |
| Tokuhira, M | 1 |
| Tabayashi, T | 1 |
| Tanaka, Y | 1 |
| Takahashi, Y | 1 |
| Kimura, Y | 1 |
| Tomikawa, T | 1 |
| Anan-Nemoto, T | 1 |
| Momose, S | 1 |
| Higashi, M | 1 |
| Okuyama, A | 1 |
| Watanabe, R | 1 |
| Amano, K | 1 |
| Tamaru, JI | 1 |
| Kizaki, M | 1 |
| Sano, H | 1 |
| Maeda, T | 1 |
| Omoto, M | 1 |
| Ogasawara, JI | 1 |
| Koga, M | 1 |
| Kawai, M | 1 |
| Kanda, T | 1 |
| Fong, WW | 1 |
| Thumboo, J | 1 |
| Azhar, R | 1 |
| Yoong, JK | 1 |
| Imashuku, S | 1 |
| Kudo, N | 1 |
| Kubo, K | 1 |
| Yachie, A | 1 |
| Olivieri, A | 1 |
| Cimminiello, M | 1 |
| Corradini, P | 1 |
| Mordini, N | 1 |
| Fedele, R | 1 |
| Selleri, C | 1 |
| Onida, F | 1 |
| Patriarca, F | 1 |
| Pavone, E | 1 |
| Svegliati, S | 1 |
| Gabrielli, A | 1 |
| Bresciani, P | 1 |
| Nuccorini, R | 1 |
| Pascale, S | 1 |
| Coluzzi, S | 1 |
| Pane, F | 1 |
| Poloni, A | 1 |
| Olivieri, J | 1 |
| Leoni, P | 1 |
| Bacigalupo, A | 2 |
| Nakao, S | 1 |
| Tan, X | 1 |
| Liu, X | 1 |
| Hu, C | 1 |
| Liu, F | 1 |
| Wu, F | 1 |
| Chen, G | 1 |
| Chen, L | 1 |
| Qin, X | 1 |
| Huang, Z | 1 |
| Xie, X | 1 |
| Li, G | 1 |
| Xu, B | 1 |
| Ueda, K | 1 |
| Ikeda, K | 1 |
| Ogawa, K | 1 |
| Sukegawa, M | 1 |
| Sano, T | 1 |
| Kimura, S | 1 |
| Suzuki, O | 1 |
| Hashimoto, Y | 1 |
| Takeishi, Y | 1 |
| Otsubo, K | 1 |
| Kanegane, H | 1 |
| Nomura, K | 1 |
| Miyawaki, T | 1 |
| Ishizawa, S | 1 |
| Masaki, Y | 1 |
| Dong, L | 1 |
| Kurose, N | 1 |
| Kitagawa, K | 1 |
| Morikawa, Y | 1 |
| Takahashi, H | 1 |
| Shinomura, Y | 1 |
| Imai, K | 1 |
| Saeki, T | 1 |
| Azumi, A | 1 |
| Nakada, S | 1 |
| Sugiyama, E | 1 |
| Matsui, S | 1 |
| Origuchi, T | 1 |
| Nishiyama, S | 1 |
| Nishimori, I | 1 |
| Nojima, T | 1 |
| Yamada, K | 1 |
| Kawano, M | 1 |
| Zen, Y | 1 |
| Kaneko, M | 1 |
| Miyazaki, K | 1 |
| Tsubota, K | 1 |
| Eguchi, K | 1 |
| Tomoda, K | 1 |
| Sawaki, T | 1 |
| Kawanami, T | 1 |
| Tanaka, M | 1 |
| Fukushima, T | 1 |
| Sugai, S | 1 |
| Umehara, H | 1 |
| Ohshima, M | 1 |
| Futamura, M | 1 |
| Kamachi, Y | 1 |
| Ito, K | 1 |
| Sakamoto, T | 1 |
| Cheng, FW | 1 |
| Lee, V | 1 |
| To, KF | 1 |
| Chan, KC | 1 |
| Shing, MK | 1 |
| Li, CK | 1 |
| Minauchi, K | 1 |
| Koizumi, K | 1 |
| Kondo, M | 1 |
| Takigami, M | 1 |
| Harada, H | 1 |
| Fujita, H | 1 |
| Mukai, M | 1 |
| Montserrat, E | 1 |
| Trappe, R | 1 |
| Oertel, S | 1 |
| Leblond, V | 1 |
| Mollee, P | 1 |
| Sender, M | 1 |
| Neuhaus, R | 1 |
| Lehmkuhl, H | 1 |
| Horst, HA | 1 |
| Salles, G | 1 |
| Morschhauser, F | 1 |
| Jaccard, A | 1 |
| Lamy, T | 1 |
| Leithäuser, M | 1 |
| Zimmermann, H | 1 |
| Anagnostopoulos, I | 1 |
| Raphael, M | 1 |
| Riess, H | 1 |
| Choquet, S | 1 |
| Tsukamoto, N | 1 |
| Handa, H | 1 |
| Yokohama, A | 1 |
| Mitsui, T | 1 |
| Saitoh, T | 1 |
| Koiso, H | 1 |
| Uchiumi, H | 1 |
| Hoshino, T | 1 |
| Karasawa, M | 1 |
| Murakami, H | 1 |
| Kojima, M | 1 |
| Nojima, Y | 1 |
| Noh, TK | 1 |
| Haw, S | 1 |
| Soung, JH | 1 |
| Won, CH | 1 |
| Chang, S | 1 |
| Choi, JH | 1 |
| Moon, KC | 1 |
| Park, YS | 1 |
| Lee, MW | 1 |
| Chow, KM | 1 |
| Szeto, CC | 1 |
| KYLE, RA | 1 |
| McPARLAND, CE | 1 |
| DAMESHEK, W | 1 |
| Ganschow, R | 1 |
| Schulz, T | 1 |
| Meyer, T | 1 |
| Broering, DC | 1 |
| Burdelski, M | 2 |
| Kontny, U | 1 |
| Boppana, S | 1 |
| Jung, A | 1 |
| Goebel, H | 1 |
| Strahm, B | 1 |
| Peters, A | 1 |
| Dormann, S | 1 |
| Werner, M | 1 |
| Bader, P | 1 |
| Fisch, P | 1 |
| Niemeyer, C | 1 |
| Kawakami, K | 1 |
| Ito, R | 1 |
| Watanabe, Y | 1 |
| Goto, T | 1 |
| Hagihara, M | 1 |
| Watanabe, S | 1 |
| Suyama, T | 1 |
| Kawa, K | 1 |
| Tateishi, T | 1 |
| Tanaka, K | 1 |
| Ito, Y | 1 |
| Mitsuo, K | 1 |
| Johnson, J | 1 |
| Kerecuk, L | 1 |
| Harrison, M | 1 |
| Taylor, JO | 1 |
| Odell, E | 1 |
| Patel, H | 1 |
| Vogl, DT | 1 |
| Aqui, N | 1 |
| Shaked, A | 1 |
| Olthoff, K | 1 |
| Markmann, J | 1 |
| Reddy, R | 1 |
| Stadtmauer, EA | 1 |
| Schuster, S | 1 |
| Tsai, DE | 1 |
| Komatsuda, A | 1 |
| Wakui, H | 1 |
| Nimura, T | 1 |
| Sawada, K | 1 |
| Gourley, I | 1 |
| Bell, AL | 1 |
| Biggart, D | 1 |
| Zhou, NN | 1 |
| Nakai, S | 1 |
| Kawakita, T | 1 |
| Oka, M | 1 |
| Nagasawa, H | 1 |
| Himeno, K | 1 |
| Nomoto, K | 1 |
| Malagó, M | 1 |
| Rogiers, X | 1 |
| Wadström, J | 1 |
| Broelsch, CE | 1 |
| Taguchi, Y | 1 |
| Purtilo, DT | 1 |
| Okano, M | 1 |
| Garrett, TJ | 1 |
| Chadburn, A | 1 |
| Barr, ML | 1 |
| Drusin, RE | 1 |
| Chen, JM | 1 |
| Schulman, LL | 1 |
| Smith, CR | 1 |
| Reison, DS | 1 |
| Rose, EA | 1 |
| Michler, RE | 1 |
| McAlister, V | 1 |
| Grant, D | 1 |
| Roy, A | 1 |
| Yilmaz, Z | 1 |
| Ghent, C | 1 |
| Wall, W | 1 |
| Schmitz, N | 1 |
| Labopin, M | 1 |
| Majolino, I | 1 |
| Laporte, JP | 1 |
| Brinch, L | 1 |
| Cook, G | 1 |
| Lambertenghi-Deliliers, G | 1 |
| Lange, A | 1 |
| Rozman, C | 1 |
| Garcia-Conde, J | 1 |
| Finke, J | 1 |
| Domingo-Albos, A | 1 |
| Gratwohl, A | 1 |
| Grosso, LE | 1 |
| Bee, CS | 1 |
| Jung, DY | 1 |
| Kim, JW | 1 |
| Lee, SK | 1 |
| Lee, WW | 1 |
| Guerci, AP | 1 |
| Burtin, P | 1 |
| Mattei, S | 1 |
| Lederlin, P | 1 |
| Chubachi, A | 1 |
| Yoshida, K | 1 |
| Endo, Y | 1 |
| Miura, A | 1 |
| Akihama, T | 1 |
| Kuwayama, A | 1 |
| Andersson, J | 1 |
| Ernberg, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Patients With Posttransplant Lymphoproliferative Disorder (PTLD) With a Sequential Treatment Consisting of Anti-CD20 Antibody Rituximab and CHOP+GCSF Chemotherapy (Including 1st+2nd Amendment)[NCT01458548] | Phase 2 | 70 participants (Actual) | Interventional | 2002-12-31 | Terminated (stopped due to This study had an major amendment in 12/2006 introducing risk stratified sequential treatment (RSST). The modified protocol is registered with NCT00590447.) | ||
| Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With 4 Courses of Rituximab SC Followed by 4 Courses of Rituximab SC, 4 Courses of Rituximab SC Combined With CHOP-21 or 6 Courses of Rituximab SC Combined With Alt[NCT02042391] | Phase 2 | 60 participants (Actual) | Interventional | 2015-02-03 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for prednisolone and Duncan Disease
| Article | Year |
|---|---|
Other iatrogenic immunodeficiency-associated lymphoproliferative disorders in a patient with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: A case report and systematic literature review.
Topics: Cyclophosphamide; Dermatomyositis; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Iatr | 2023 |
IgG4-related disease in Singapore: a description of two cases and review of the literature.
Topics: Adult; Ampulla of Vater; Autoimmune Diseases; Common Bile Duct Diseases; Diagnosis, Differential; Gl | 2013 |
[Recent issues and prospects of the treatment of aplastic anemia].
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Benzoates; Biomarkers; Cyclosporine; Drug Therapy, | 2014 |
Systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder: a case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cyclophosphamide; Doxorub | 2014 |
[Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].
Topics: Adult; Brain Diseases; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproli | 2011 |
[Diagnosis and treatment for EBV-associated lymphoproliferative disease].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chronic Disease; Epste | 2006 |
[Chronic T-cell lymphoproliferative disorder associated with pure red cell aplasia].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphoproliferativ | 1989 |
Management of Epstein-Barr virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Burkitt Lymphoma; Clinical Trials as Topic; Female; H | 1988 |
3 trials available for prednisolone and Duncan Disease
| Article | Year |
|---|---|
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Autoantibodies; Benzamides; Chronic Disease; Disease-F | 2013 |
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2012 |
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2012 |
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2012 |
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Comb | 2012 |
Management of Epstein-Barr virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Burkitt Lymphoma; Clinical Trials as Topic; Female; H | 1988 |
35 other studies available for prednisolone and Duncan Disease
| Article | Year |
|---|---|
In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Topics: Calcineurin; Cyclosporine; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppre | 2022 |
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
Topics: Agammaglobulinemia; Age of Onset; Anemia, Hemolytic, Autoimmune; Child; Cyclosporine; Cytochrome P-4 | 2020 |
Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
Topics: Aged; Autoantibodies; DNA, Viral; Epstein-Barr Virus Infections; Factor VIII; Hemophilia A; Herpesvi | 2021 |
The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Arthritis, Rheumatoid; Female; Hodgkin Disea | 2017 |
Steroid-responsive demyelinating peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells.
Topics: Administration, Oral; Aged; Biomarkers; Chronic Disease; Demyelinating Diseases; Female; Humans; Kil | 2017 |
Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Drug Therapy, Combination; Etoposide; Humans; | 2013 |
Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Topics: Biopsy; Epstein-Barr Virus Infections; Fatal Outcome; Female; Glucocorticoids; Herpesvirus 4, Human; | 2014 |
Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Topics: Autoimmune Diseases; B-Lymphocytes; Cyclophosphamide; Drug Therapy, Combination; Epstein-Barr Virus | 2016 |
Atypical lymphoproliferative disorder in a patient with X-linked thrombocytopenia.
Topics: Child, Preschool; Genetic Diseases, X-Linked; Humans; Lymphoproliferative Disorders; Positron-Emissi | 2008 |
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Glucocorticoids | 2009 |
Allergic bronchopulmonary aspergillosis in a 2-year-old asthmatic boy with immune dysregulation, polyendocrinopathy, enteropathy, X-linked.
Topics: Aspergillosis, Allergic Bronchopulmonary; Asthma; Child, Preschool; Eczema; Endocrine System Disease | 2009 |
Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
Topics: Acyclovir; Adrenoleukodystrophy; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Ant | 2009 |
PTLD treatment: a step forward, a long way to go.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus.
Topics: Adult; Aging; Epstein-Barr Virus Infections; Female; Glucocorticoids; Herpesvirus 4, Human; Humans; | 2011 |
Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders.
Topics: Adolescent; Anti-Inflammatory Agents; Diagnosis, Differential; Epstein-Barr Virus Infections; Female | 2012 |
Hyponatraemia in a woman with a pelvic mass.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Hypon | 2003 |
Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders.
Topics: Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders | 1962 |
Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; DNA, Viral; Epstein-Barr Virus Infections; Female | 2004 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic | 2005 |
[Effective treatment for a methotrexate-associated lymphoproliferative disorder with R-CHOP following administration of rituximab].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2005 |
[Epstein-Barr virus related B-cell lymphoproliferative disorder complicated with bone marrow fibrosis, which was successfully treated with 2 courses of CHOP regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; B-Lymphocytes; Cyclophosphamide; D | 2005 |
[Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].
Topics: Adult; Brain; Humans; Lung; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Magn | 2006 |
Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.
Topics: Antineoplastic Agents; Biopsy; Child; Cyclophosphamide; Diagnosis, Differential; Epstein-Barr Virus | 2007 |
Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2007 |
Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Drug Therapy, Combinati | 2008 |
Kikuchi's disease as a presenting feature of mixed connective tissue disease.
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescent Ant | 1995 |
Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus suboptimal dosage of prednisolone.
Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; DNA; Drug Therapy, Combination; Drugs, Chines | 1994 |
Optimal clinical regimens for living related liver transplantation.
Topics: Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Drug Administration Sched | 1994 |
The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.
Topics: alpha 1-Antitrypsin Deficiency; Antigens, Viral; Capsid; Child, Preschool; Cyclosporine; DNA-Binding | 1994 |
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immuno | 1993 |
Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Incid | 1993 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Fe | 1996 |
T-cell rich, Ki-1-positive post-transplant lymphoproliferative disorder: a previously undescribed variant following liver transplant.
Topics: Cyclosporine; DNA; Fatal Outcome; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunophenotyping | 1998 |
Epstein-Barr virus-associated lymphoproliferative skin lesion with recurrent necrotic papulovesicles of the face.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Burkitt Lymphoma; Facial Dermatoses; Herpesvirus 4, Human; | 1999 |
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunos | 1992 |